Mexico Business says food makers are responding to the drop in grocery spending by changing portion sizes and nutrition in their products.
Recap by typeshit. Post by Mexico Business on X.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
Obesity doctor Spencer Nadolsky goes after misconceptions about the triple agonist still in trials. Tap through to see which claims he pushes back on.
A TriNetX study of 4,253 matched patients per group, shown at ACG 2026, found roughly half the MACE risk at one year with resmetirom. Retrospective data, so no causation.
Loading…